MMRC Horizon One: RRMM (MMRC-099)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Hearn J Cho, MD, PhD
Multiple Myeloma Research Foundation
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope
Duarte, California, United States
- Emory Winship Cancer Center
Atlanta, Georgia, United States
- University of Chicago Cancer Center
Chicago, Illinois, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Dana Farber Cancer Institute/harvard Medical School
Boston, Massachusetts, United States
- Barbara Ann Karmanos Cancer Center
Detroit, Michigan, United States
- Mayo Clinic Rochester
Rochester, Minnesota, United States
- Washington University Medicine
St Louis, Missouri, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Mt. Sinai School of Medicine
New York, New York, United States
- Atrium Levine Cancer Institute
Charlotte, North Carolina, United States
- Tennessee Oncology
Nashville, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Nov 2024
- Primary completion
- 31 Jul 2029
- Completion
- 31 Jul 2030
- Last update posted
- 5 Jun 2026
- Registered enrollment
- 300
- Registry id
- NCT06171685
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.